TY - JOUR
T1 - Prognostic Value of Coronary Artery Calcium Score in Hospitalized COVID-19 Patients
AU - Luchian, Maria-Luiza
AU - Lochy, Stijn
AU - Motoc, Andreea
AU - Belsack, Dries
AU - Magne, Julien
AU - Roosens, Bram
AU - de Mey, Johan
AU - Tanaka, Kaoru
AU - Scheirlynck, Esther
AU - Boeckstaens, Sven
AU - Van den Bussche, Karen
AU - De Potter, Tom
AU - von Kemp, Berlinde
AU - Galloo, Xavier
AU - François, Clara
AU - Weytjens, Caroline
AU - Droogmans, Steven
AU - Cosyns, Bernard
N1 - Copyright © 2021 Luchian, Lochy, Motoc, Belsack, Magne, Roosens, de Mey, Tanaka, Scheirlynck, Boeckstaens, Van den Bussche, De Potter, von Kemp, Galloo, François, Weytjens, Droogmans and Cosyns.
PY - 2021/7/9
Y1 - 2021/7/9
N2 - Background: The association of known cardiovascular risk factors with poor prognosis of coronavirus disease 2019 (COVID-19) has been recently emphasized. Coronary artery calcium (CAC) score is considered a risk modifier in the primary prevention of cardiovascular disease. We hypothesized that the absence of CAC might have an additional predictive value for an improved cardiovascular outcome of hospitalized COVID-19 patients. Materials and methods: We prospectively included 310 consecutive hospitalized patients with COVID-19. Thirty patients with history of coronary artery disease were excluded. Chest computed tomography (CT) was performed in all patients. Demographics, medical history, clinical characteristics, laboratory findings, imaging data, in-hospital treatment, and outcomes were retrospectively analyzed. A composite endpoint of major adverse cardiovascular events (MACE) was defined. Results: Two hundred eighty patients (63.2 ± 16.7 years old, 57.5% male) were included in the analysis. 46.7% patients had a CAC score of 0. MACE rate was 21.8% (61 patients). The absence of CAC was inversely associated with MACE (OR 0.209, 95% CI 0.052-0.833, p = 0.027), with a negative predictive value of 84.5%. Conclusion: The absence of CAC had a high negative predictive value for MACE in patients hospitalized with COVID-19, even in the presence of cardiac risk factors. A semi-qualitative assessment of CAC is a simple, reproducible, and non-invasive measure that may be useful to identify COVID-19 patients at a low risk for developing cardiovascular complications.
AB - Background: The association of known cardiovascular risk factors with poor prognosis of coronavirus disease 2019 (COVID-19) has been recently emphasized. Coronary artery calcium (CAC) score is considered a risk modifier in the primary prevention of cardiovascular disease. We hypothesized that the absence of CAC might have an additional predictive value for an improved cardiovascular outcome of hospitalized COVID-19 patients. Materials and methods: We prospectively included 310 consecutive hospitalized patients with COVID-19. Thirty patients with history of coronary artery disease were excluded. Chest computed tomography (CT) was performed in all patients. Demographics, medical history, clinical characteristics, laboratory findings, imaging data, in-hospital treatment, and outcomes were retrospectively analyzed. A composite endpoint of major adverse cardiovascular events (MACE) was defined. Results: Two hundred eighty patients (63.2 ± 16.7 years old, 57.5% male) were included in the analysis. 46.7% patients had a CAC score of 0. MACE rate was 21.8% (61 patients). The absence of CAC was inversely associated with MACE (OR 0.209, 95% CI 0.052-0.833, p = 0.027), with a negative predictive value of 84.5%. Conclusion: The absence of CAC had a high negative predictive value for MACE in patients hospitalized with COVID-19, even in the presence of cardiac risk factors. A semi-qualitative assessment of CAC is a simple, reproducible, and non-invasive measure that may be useful to identify COVID-19 patients at a low risk for developing cardiovascular complications.
KW - Corona virus
KW - chest computed tomography
KW - coronary artery calcium score
KW - major adverse cardiac and cerebral event
KW - risk stratification
UR - http://www.scopus.com/inward/record.url?scp=85126545999&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2021.684528
DO - 10.3389/fcvm.2021.684528
M3 - Article
C2 - 34307498
VL - 8
JO - Frontiers in cardiovascular medicine
JF - Frontiers in cardiovascular medicine
SN - 2297-055X
M1 - 684528
ER -